Rocket Doctor Expands U.S. Coverage, Becoming In-Network with Two Leading National Insurers With More Than 6.5 Million Additional Members Across California and New York State
Rocket Doctor (OTC:AIRDF) announced on October 21, 2025 that its Rocket Doctor platform is now in-network with two additional U.S. payers, expanding coverage by approximately 6.5 million members across California and New York.
The agreements (signed on October 9 and 10, 2025) add ~2.7 million covered lives in California and ~3.8 million in New York, bringing Rocket Doctor’s total in-network reach to well over 13 million members. The contracts span commercial, Medicare Advantage, and Veterans coverage and aim to broaden access to AI-powered, physician-led primary, urgent, chronic and mental healthcare.
Rocket Doctor (OTC:AIRDF) ha annunciato il 21 ottobre 2025 che la sua piattaforma Rocket Doctor è ora in rete con due ulteriori assicuratori negli Stati Uniti, ampliando la copertura di circa 6,5 milioni di membri in California e New York.
Gli accordi (firmati il 9 e 10 ottobre 2025) aggiungono ~2,7 milioni di persone coperte in California e ~3,8 milioni in New York, portando la copertura in-network di Rocket Doctor a oltre 13 milioni di membri. I contratti coprono assicurazione commerciale, Medicare Advantage e Veterans, e mirano ad ampliare l’accesso a cure principali, urgenti, croniche e mentali affidate a IA e guidate da medici.
Rocket Doctor (OTC:AIRDF) anunció el 21 de octubre de 2025 que su plataforma Rocket Doctor ya forma parte de la red de dos aseguradores adicionales en Estados Unidos, ampliando la cobertura en aproximadamente 6,5 millones de miembros en California y Nueva York.
Los acuerdos (firmados el 9 y 10 de octubre de 2025) añaden ~2,7 millones de asegurados en California y ~3,8 millones en Nueva York, llevando el alcance en-network de Rocket Doctor a más de 13 millones de miembros. Los contratos abarcan cobertura comercial, Medicare Advantage y Veterans, y buscan ampliar el acceso a atención primaria, urgente, crónica y mental impulsada por IA y liderada por médicos.
Rocket Doctor (OTC:AIRDF)가 2025년 10월 21일에 로켓 닥터 플랫폼이 미국 내 두 개의 추가 보험사와 네트워크에 합류했으며, 캘리포니아와 뉴욕에서 약 6.5백만 명의 커버리지가 확대되었다고 발표했습니다.
그 계약은 2025년 10월 9일과 10일에 체결되었으며 캘리포니아에서 약 270만 명, 뉴욕에서 약 380만 명의 피보험자를 추가하여 Rocket Doctor의 네트워크 상 이용 가능한 총 규모를 1300만 명 이상으로 끌어올립니다. 계약은 상업보험, Medicare Advantage, 및 재향군인 보장을 포괄하며 AI 기반의 의사 주도 1차 진료, 응급, 만성 및 정신 건강 관리에 대한 접근을 확대하는 것을 목표로 합니다.
Rocket Doctor (OTC:AIRDF) a annoncé le 21 octobre 2025 que sa plateforme Rocket Doctor est désormais en réseau avec deux assureurs américains supplémentaires, élargissant la couverture d’environ 6,5 millions de membres en Californie et à New York.
Les accords (signés les 9 et 10 octobre 2025) ajoutent ~2,7 millions de personnes couvertes en Californie et ~3,8 millions à New York, portant la portée du réseau de Rocket Doctor à plus de 13 millions de membres. Les contrats couvrent les assurances commerciales, Medicare Advantage et Veterans, et visent à élargir l’accès aux soins primaires, urgents, chroniques et mentaux, pilotés par l’IA et dirigés par des médecins.
Rocket Doctor (OTC:AIRDF) hat am 21. Oktober 2025 bekannt gegeben, dass seine Plattform Rocket Doctor nun mit zwei weiteren US-Versicherern vernetzt ist, wodurch rund 6,5 Millionen Mitglieder in Kalifornien und New York abgedeckt werden.
Die Vereinbarungen (unterzeichnet am 9. und 10. Oktober 2025) fügen ca. 2,7 Millionen versicherte Personen in Kalifornien und ca. 3,8 Millionen in New York hinzu, wodurch die in-network-Abdeckung von Rocket Doctor insgesamt auf deutlich über 13 Millionen Mitglieder anwächst. Die Verträge decken kommerzielle, Medicare Advantage- und Veterans-Versicherungen ab und zielen darauf ab, den Zugang zu KI-gestützter, ärztlich geleiteter primärer, dringlicher, chronischer und psychischer Gesundheitsversorgung zu erweitern.
Rocket Doctor (OTC:AIRDF) أعلن عن 21 أكتوبر 2025 أن منصة Rocket Doctor أصبحت الآن ضمن شبكة مزودين اثنين إضافيين في الولايات المتحدة، مع توسيع التغطية بنحو 6.5 مليون عضو في كاليفورنيا ونيويورك.
اتفاقيات (وقعتها في 9 و10 أكتوبر 2025) تضيف ~2.7 مليون من الأشخاص المؤمن عليهم في كاليفورنيا و ~3.8 مليون في نيويورك، ليصل إجمالي الوصول الشبكي لـ Rocket Doctor إلى أكثر من 13 مليون عضو. تمتد العقود لتشمل التغطية التجارية وMedicare Advantage وVeterans، وتهدف إلى توسيع الوصول إلى الرعاية الأولية والطارئة والمزمنة والصحية العقلية المعتمدة على الذكاء الاصطناعي وقيادة الأطباء.
Rocket Doctor (OTC:AIRDF) 宣布 2025年10月21日 其 Rocket Doctor 平台现已与美国另外两家保险公司互联网络,覆盖范围扩大约 650万 名成员,覆盖范围涵盖加利福尼亚州和纽约州。
这些协议(于 2025年10月9日和10日 签署)在加州新增约 270万 受保人,在纽约新增约 380万,使 Rocket Doctor 的在网覆盖总数达到超过 1300万 名成员。合同涵盖商业保、Medicare Advantage 与 Veterans 保障,旨在通过 AI 驱动的医生主导的初级护理、急诊、慢性和心理健康护理,扩大获取。
- In-network reach expanded by 6.5 million members
- Adds ~2.7 million covered lives in California
- Adds ~3.8 million covered lives in New York
- Total in-network reach now > 13 million members
- Includes coverage for Veterans across multiple states
- None.
- These new agreements include approximately 2.7 million members in California under one major insurer and 3.8 million members in New York under two major insurers, extending Rocket Doctor’s total in-network reach to over 13 million members nationwide.
- This milestone builds on Rocket Doctor’s October 8th announcement, which detailed new payer contracts covering more than 7 million members across both states.
- The partnership strengthens Rocket Doctor’s ability to deliver AI-powered, physician-led primary, urgent, and mental health care, advancing its mission to improve access, equity, and affordability in healthcare.
New York, NY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with two new leading U.S. healthcare payers. These new agreements expand Rocket Doctor’s ability to now deliver care to more than 13 million insured members across California and New York State.
The new partnerships signed on 9th and 10th October respectively, span members who are commercially insured, on Medicare Advantage and Veteran Affairs, significantly broadening access to Rocket Doctor’s physician-led, AI-powered healthcare platform. These new partnerships mark the first step into providing equitable access to care to Veterans across multiple states.
The company’s integrated digital ecosystem brings together urgent care, primary care, chronic disease management, and mental health services, supported by advanced clinical AI and connected medical devices.
According to 2025 market data from the California Health Care Foundation and the Centers for Medicare & Medicaid Services (CMS), the agreements include approximately 2.7 million covered lives in California, combining insured and self-funded members, and an additional 3.8 million members in New York across Medicare Advantage and other plan types. In total, the new coverage extends Rocket Doctor’s reach by a further 6.5 million members nationwide.
This announcement follows Rocket Doctor’s October 8th news release, which detailed new payer contracts providing access to over 7 million members across California and New York. The addition of this latest agreement brings Rocket Doctor’s total in-network reach to well over 13 million covered lives across key U.S. markets, reinforcing the company’s rapid growth and expanding impact on healthcare accessibility.
“This marks a major milestone in our U.S. expansion,” said Dr. William Cherniak, CEO of Rocket Doctor Inc. “By joining networks that collectively cover millions of members across California and New York, we’re making high-quality, affordable healthcare accessible to more patients than ever, from large urban areas to rural and underserved regions. Further, expanding our network to include Veterans is a meaningful addition to our ability to support accessible care. This partnership reflects our ongoing commitment to reducing barriers to care through innovation and technology.”
Rocket Doctor’s platform enables patients to connect with Board Certified physicians using AI-driven clinical tools to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes. The platform’s design ensures full compliance with HIPAA standards, while delivering secure, efficient, and scalable care.
Patients covered under these agreements can confirm eligibility through the Rocket Doctor patient-intake page, which provides easy access to plan information and state-specific coverage details.
By extending access to millions of patients across the nation’s largest healthcare markets, Rocket Doctor continues to strengthen its position as a trusted partner to both payers and providers, advancing its mission to improve access, equity, and affordability through technology-driven healthcare.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
